Cancer cells cause vascular endothelial cell (vEC) retraction via 12(S)HETE secretion; the possible role of cancer cell derived microparticle

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 862-868

  Uchide, Keiji ^a   Sakon, Masato ^a   Ariyoshi, Hideo ^a   Nakamori, Syouji ^a   Tokunaga, Masaru ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

12(S)HETE; Cancer cell; Cancer metastasis; Endothelial cell retraction; Microparticles

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ANTIBODY; ARACHIDONIC ACID; LIPID; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; TRYPSIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL ACTIVITY; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOMETRY; ENDOTHELIUM CELL; EXTRACTION; HUMAN; HUMAN CELL; NONHUMAN; THIN LAYER CHROMATOGRAPHY; ULTRACENTRIFUGATION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FEMALE; HUMANS; NEOPLASM METASTASIS;

EID: 33846570421     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9225-3     Document Type: Article

References (23)

1. Fidler IJ, Gerstein DM, Hart IR. The biology of cancer invasion and metastasis. Advanc Cancer Res 1978; 28:149-250.
2. Nicolson GL. Organ colonization and the cell-surface properties of malignant cells. Biochem biophys Acta 1982; 695:113-76.
3. Carr I, McGinty F, Norris P. The fine structure of neoplastic invasion:invasion of liver,skeletal muscle and lymphatic vessels by the Rd/3 tumour. J pathol 1976; 118:91-99.
4. Akedo H, Shinkai K, Mukai M, et al. Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers:a model for tumor invasion. Cancer Res 1986; 46:2416-22.
5. Ohigashi H, Shinkai K, Mukai M, et al. In vitro invasion of endothelial cell monolayer by rat ascites hepatoma cells. Jpn J Cancer Res 1989; 80:818-21.
6. Zetter BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol Aug 1993; 4(4):219-29.
7. Nakamori S, Okamoto H, et al. Increased endothelial cell retraction and tumor cell invasion by soluble factors derived from pancreatic cancer cells. Ann Surg Oncol 1997; 4:361-368.
8. Shibuya M. Angiogenesis-vascular endothelial growth factor and its receptors. Hum Cell 1999; 12(1):17-24.
9. David M, Humphrey Linda M, McManus, Kiyoshi Satoguchi, et al. Vasoactive Properties of Acetyl Glyceryl Ether Phosphorylcholine and Analogues. Lab Invest 1982; 42:422-427.
10. Kusama T, Nakamori S, et al. Enhancement of in vitro tumor-cell transcellular migration by tumor-cell-secreted endothelial-cell-retraction factor. Int J Cancer 1995; 63:112-118.
11. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Bioch Physiol 1959; 37:911-917.
12. Okuma M, Uchino H. Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. Blood 1979; 54(6):1258-71.
13. Yamamoto T, Nagano H, Sakon M, et al. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Clin Cancer Res 2004; 10(23):7884-95.
14. Majno G, Palade GE. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 1961; 11:571-605.
15. Dahlen SE, Jakob Bjork, Per Hedqvist, et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules. Proc Natl Acad Sci 1988; 78:3887-3891.
16. Rabiet MJ, Plantier JL, Rival Y, et al. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol 1996; 16(3):488-96.
17. Burke-Gaffney A, Keenan AK. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma. Immunopharmacology 1993; 25(1):1-9.
18. Maruo N, Morita I, Shirao M, et al. IL-6 increases endothelial permeability in vitro. Endocrinology 1992; 131(2):710-4.
19. Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 2001; 280(6):1094-1103.
20. Horvath CJ, Ferro J, Thomas, Jesmok Gary, et al. Recombinant tumor necrosis factor increase pulmonary vascular permeability independent of neutrophils. Proc Natil Acad Sci 1988; 85:9219-9223.
21. Kenneth V, Honn Dean G, Tang, et al. Tumo cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Research 1994; 54:565-574.
22. Kenneth V, Honn Irma M, Grossi, et al. Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction. The FASEB J 1989; 2285-2293.
23. Iwamoto S, Kawasaki T, Kambayashi J, et al. Platelet Microparticles: A carrier of Platelet-Activating Factor?. Biochem Biophys Res Commun 1996; 218(3):940-944.